Vaginal Progesterone in Asymptomatic Women with Short Cervical Length on Ultrasound: is it Beneficial?

Journal of Fetal Medicine - 2015
Anjali Gupta1, Suman Sharan1, Jyotsna Sen2
1Department of Obstetrics & Gynecology, Pt. B.D. Sharma, PGIMS, 124001, Rohtak, Haryana, India
2Department of Radiology, Pt. B.D. Sharma, Post Graduate Institute of Medical Sciences, Rohtak, India

Tóm tắt

AbstractThe aim of the present study was to determine the efficacy of vaginal progesterone in asymptomatic women with a sonographic short cervix (≤25 mm) at 18–24 weeks of gestation in reducing the risk of preterm birth. It was a prospective observational study carried out on 60 pregnant women attending the antenatal clinic in tertiary health institute between 18 and 24 weeks of gestation with ultrasonographically-measured short cervix. The women with cervical length ≤25 mm were alternately divided into two groups of 30 each. Group I was given 200 mg vaginal micronized progesterone capsules and Group II was managed expectantly. Primary outcome was measured as spontaneous birth before 34 weeks of gestation. Secondary outcome was birth at <32 weeks, <37 weeks and the neonatal outcome. The demographic profile of women in both the groups was similar. The rate of spontaneous delivery before 34 and 37 weeks of gestation was significantly less in the progesterone group (3 vs 20 %; p = 0.044, 6.6 vs 26.7 %; p = 0.038). There was no difference in birth weight <2500 g and Apgar score <7 at 5 min in neonates of both the groups. Progesterone was associated with a significant reduction in composite neonatal morbidity (6.7 vs 33.3 %; p = 0.020). There were no serious adverse events associated with the use of progesterone. Thus, in a woman with short cervical length, vaginal progesterone significantly lowers the preterm birth rate and composite neonatal morbidity.

Từ khóa


Tài liệu tham khảo

Royal College of Obstetricians and Gynaecologists (RCOG). Tocolysis for women in preterm labor. Green-top Guideline No. 1B; 2002.

Lawn JE, Cousens SN, Darmstadt GL, et al. 1 year after the Lancet neonatal survival series—was the call for action heard? Lancet. 2006;367:1541–7.

Arisoy R, Yayla M. Transvaginal sonographic evaluation of the cervix in asymptomatic singleton pregnancy and management options in short cervix. J Pregnancy 2012;2012:201628:doi: 10.1155/2012/201628.epub.2012 .

Norwitz ER, Caughey AB. Progesterone supplementation and prevention of preterm birth. Rev Obstet Gynecol. 2011;4(2):60–72.

Romero R, Yeo L, Miranda J, et al. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med. 2013;41:27–44.

Mauldin JG, Newman RB. Preterm birth risk assessment. Semin Perinatol. 2001;25:215–22.

Cook CM, Ellwood DA. A longitudinal study of the cervix in pregnancy using transvaginal ultrasound. Br J Obstet Gynecol. 1996;103:16–8.

Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996;334:567–72.

Khandelwal M. Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the mid-trimester of pregnancy. Int J Women’s Health. 2012;4:481–90.

Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol. 2011;38:1–9.

Cicinelli E, de Ziegler D, Bulletti C, et al. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95:403–6.

Miles RA, Paulson RJ, Lobo RA, et al. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril. 1994;62:485–90.

Romero R, Nicolaides K, Conde-Agudelo A, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the mid-trimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206:124.e1–19.

Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history. Ultrasound Obstet Gynecol. 1998;12:304–11.

Schleubner E. The prevention, diagnosis and treatment of premature labor. Dtsch Arztebl Int. 2013;110(13):227–36.

Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008;31:579–87.

Maher MA, Abdelaziz A, Ellaithy M, et al. Prevention of preterm birth: a Randomised trial of vaginal compared with intramuscular progesterone. Acta Obstet Gynecol Scand. 2013;92:215–22.

Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–9.

Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18–31.

DeFranco EA, O’Brien JM, Adair CD, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30:697–705.

Thông tin
Thông tin xuất bản

Journal of Fetal Medicine

Thông tin tác giả